Osteoporosis Trial, Recruiting NCT06853132 Sponsor: Yale University Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT06853132
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a lumbar disc herniation (a slipped disc in the lower back) and osteoporosis (weakened, brittle bones), based on their medical records and clinical assessment.
  • Female patients aged 45 or older, or male patients aged 50 or older.
  • People who rate their pain at 3 or more out of 10 on a standard pain scale.
  • People who are scheduled to have surgery during a 7-day hospital stay.
  • People who speak Mandarin.

Who may not be able to join:

  • People who have been diagnosed with certain serious health conditions, including ulcerative colitis, gastrointestinal bleeding, pancreatitis, lung cancer, pneumonia, acute respiratory distress syndrome, psychosis, depression, anxiety, or substance abuse.
  • People who have been regularly physically active in the 3 months before the trial — specifically, those doing aerobic exercise for at least 30 minutes, at least 3 times per week.
  • People who have taken certain medications in the 3 months before joining the trial, including bisphosphonates (bone-strengthening drugs), glucocorticoids (steroid medicines), calcitonin, anticonvulsant drugs (used for seizures or nerve pain), or heparin (a blood thinner).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN, Yale University

Phone: 510-290-2387

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
30 August 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Change in Quality of life measured by the Oswestry Disability Index (ODI); Change in Muscle strength by the Five Times Sit-to-Stand Test (FTSS); Change in physical activity level by the International Physical Activity Questionnaire (IPAQ).

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov